{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:31:45Z","timestamp":1791639105561,"version":"4.3.4"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>Myopia or short-sightedness is an emerging pandemic affecting more than 50% population in South-Asian countries. It is associated with several sight-threatening complications, such as retinal detachment and choroidal neovascularization, leading to an increased burden of visual impairment and blindness. The pathophysiology of myopia involves a complex interplay of numerous environmental and genetic factors leading to progressive axial elongation. Environmental factors such as decreased outdoor activity, reduced exposure to ambient light, strenuous near work, and role of family history of myopia have been implicated with increased prevalence of this refractive error. While multiple clinical trials have been undertaken to devise appropriate treatment strategies and target the modifiable risk factors, there is no single treatment modality with ideal results; therefore, formulating a comprehensive approach is required to control the myopia epidemic. This review article summarizes the epidemiology, dynamic concepts of pathophysiology, and evolution of the treatment modalities for myopia such as pharmacological (atropine and other agents) and optical methods (spectacles, contact lenses, and orthokeratology).<\/jats:p>","DOI":"10.4103\/ijo.ijo_2098_21","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T11:45:11Z","timestamp":1659613511000},"page":"2800-2815","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["Current concepts in the management of childhood myopia"],"prefix":"10.4103","volume":"70","author":[{"given":"Rebika","family":"Dhiman","sequence":"first","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Rakheja","sequence":"additional","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Gupta","sequence":"additional","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Saxena","sequence":"additional","affiliation":[{"name":"Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2013.256","article-title":"Myopia, an underrated global challenge to vision:Where the current data takes us on myopia control","volume":"28","author":"Holden","year":"2014","journal-title":"Eye"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/OPX.0b013e3181c95a24","article-title":"Hereditary and environmental contributions to emmetropization and myopia","volume":"87","author":"Mutti","year":"2010","journal-title":"Optom Vis Sci"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/OPX.0000000000000796","article-title":"Global vision impairment and blindness due to uncorrected refractive error, 1990-2010","volume":"93","author":"Naidoo","year":"2016","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","article-title":"Causes of vision loss worldwide, 1990-2010:A systematic analysis","volume":"1","author":"Bourne","year":"2013","journal-title":"Lancet Glob Health"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.47102\/https:\/\/doi.org\/10.47102\/annals-acadmedsg.V33N1p27","article-title":"Prevalence of myopia in Taiwanese schoolchildren:1983 to 2000","volume":"33","author":"Lin","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/bjophthalmol-2015-307724","article-title":"Global variations and time trends in the prevalence of childhood myopia, a systematic review and quantitative meta-analysis:Implications for aetiology and early prevention","volume":"100","author":"Rudnicka","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.opx.0000134905.98403.18","article-title":"Prevalence of myopia in local and international schools in Hong Kong","volume":"81","author":"Lam","year":"2004","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"B9-20240828","first-page":"495","article-title":"The prevalence of refractive errors among adults in the United States, Western Europe, and Australia","volume":"122","author":"Kempen","year":"2004","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"B10-20240828","first-page":"623","article-title":"Refractive error in children in an urban population in New Delhi","volume":"43","author":"Murthy","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"e0189774","DOI":"10.1371\/journal.pone.0189774","article-title":"Incidence and progression of myopia and associated factors in urban school children in Delhi:The North India myopia study (NIM Study)","volume":"12","author":"Saxena","year":"2017","journal-title":"PLoS One"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"e0117349","DOI":"10.1371\/journal.pone.0117349","article-title":"Prevalence of myopia and its risk factors in urban school children in Delhi:The North India Myopia Study (NIM Study)","volume":"10","author":"Saxena","year":"2015","journal-title":"PLoS One"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1167\/iovs.06-0562","article-title":"Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia","volume":"48","author":"Mutti","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cxo.12312","article-title":"Animal models in myopia research","volume":"98","author":"Schaeffel","year":"2015","journal-title":"Clin Exp Optom"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ajo.2013.01.014","article-title":"Intravitreal bevacizumab for retinopathy of prematurity:Refractive error results","volume":"155","author":"Harder","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2013.02.007","article-title":"An updated view on the role of dopamine in myopia","volume":"114","author":"Feldkaemper","year":"2013","journal-title":"Exp Eye Res"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00417-006-0254-1","article-title":"Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits","volume":"244","author":"Gao","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2016.12.061","article-title":"Different roles of retinal dopamine in albino Guinea pig myopia","volume":"639","author":"Mao","year":"2017","journal-title":"Neurosci Lett"},{"key":"B19-20240828","first-page":"464","article-title":"Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia","volume":"15","author":"McBrien","year":"2009","journal-title":"Mol Vis"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1167\/iovs.04-0258","article-title":"Effects of pirenzepine on pupil size and accommodation in rhesus monkeys","volume":"45","author":"Ostrin","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s12013-014-0359-9","article-title":"Pirenzepine inhibits myopia in guinea pig model by regulating the balance of MMP-2 and TIMP-2 expression and increased tyrosine hydroxylase levels","volume":"71","author":"Qian","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1350-9462(02)00063-0","article-title":"Role of the sclera in the development and pathological complications of myopia","volume":"22","author":"McBrien","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"B24-20240828","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaophthalmol.2015.0471","article-title":"Prediction of juvenile-onset myopia","volume":"133","author":"Zadnik","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"M20","DOI":"10.1167\/iovs.18-25957","article-title":"IMI \u2013Defining and classifying myopia:A proposed set of standards for clinical and epidemiologic studies","volume":"60","author":"Flitcroft","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B26-20240828","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/OPX.0000000000000067","article-title":"The Cambridge anti-myopia study:Variables associated with myopia progression","volume":"90","author":"Price","year":"2013","journal-title":"Optom Vis Sci"},{"key":"B27-20240828","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1167\/iovs.03-1155","article-title":"Family aggregation of high myopia:Estimation of the sibling recurrence risk ratio","volume":"45","author":"Farbrother","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B28-20240828","first-page":"3633","article-title":"Parental myopia, near work, school achievement, and children's refractive error","volume":"43","author":"Mutti","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B29-20240828","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1167\/iovs.14-14640","article-title":"The contributions of near work and outdoor activity to the correlation between siblings in the Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) study","volume":"55","author":"Jones-Jordan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B30-20240828","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7150\/ijms.12133","article-title":"Risk factors of myopic shift among primary school children in Beijing, China:A prospective study","volume":"12","author":"Wu","year":"2015","journal-title":"Int J Med Sci"},{"key":"B31-20240828","doi-asserted-by":"crossref","first-page":"M184","DOI":"10.1167\/iovs.18-25977","article-title":"IMI \u2013clinical management guidelines report","volume":"60","author":"Gifford","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B32-20240828","doi-asserted-by":"crossref","first-page":"63","DOI":"10.11622\/smedj.2019144","article-title":"School-based programme to address childhood myopia in Singapore","volume":"62","author":"Karuppiah","year":"2021","journal-title":"Singapore Med J"},{"key":"B33-20240828","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1167\/iovs.07-0804","article-title":"Role of near work in myopia:Findings in a sample of Australian school children","volume":"49","author":"Ip","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B34-20240828","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09286586.2020.1862243","article-title":"Digital eye strain epidemic amid COVID-19 pandemic-A cross-sectional survey","volume":"28","author":"Ganne","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"key":"B35-20240828","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1111\/aos.12776","article-title":"Inverse relationship between sleep duration and myopia","volume":"94","author":"Jee","year":"2016","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B36-20240828","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.exer.2017.06.003","article-title":"Brief hyperopic defocus or form deprivation have varying effects on eye growth and ocular rhythms depending on the time-of-day of exposure","volume":"161","author":"Nickla","year":"2017","journal-title":"Exp Eye Res"},{"key":"B37-20240828","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bjo.85.5.521","article-title":"Myopia in Singapore:Taking a public health approach","volume":"85","author":"Seet","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"B38-20240828","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia:Aetiology and prevention","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"B39-20240828","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1167\/iovs.14-15474","article-title":"Time outdoors and myopia progression over 2 years in Chinese children:The Anyang childhood eye study","volume":"56","author":"Li","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B40-20240828","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.6.3.20","article-title":"Development of the FitSight fitness tracker to increase time outdoors to prevent myopia","volume":"6","author":"Verkicharla","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"B41-20240828","doi-asserted-by":"crossref","first-page":"e17992","DOI":"10.1097\/MD.0000000000017992","article-title":"An effectiveness study of a wearable device (Clouclip) intervention in unhealthy visual behaviors among school-age children:A pilot study","volume":"99","author":"Cao","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B42-20240828","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/opo.12052","article-title":"How does atropine exert its anti-myopia effects?","volume":"33","author":"McBrien","year":"2013","journal-title":"Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt Optom"},{"key":"B43-20240828","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","article-title":"Atropine for the treatment of childhood myopia:Changes after stopping atropine 0.01%, 0.1% and 0.5%","volume":"157","author":"Chia","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"B44-20240828","first-page":"3119","article-title":"Efficacy results from the Atropine in the Treatment of Myopia (ATOM) study","volume":"44","author":"Chua","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B45-20240828","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","article-title":"Atropine for the treatment of childhood myopia:Effect on myopia progression after cessation of atropine","volume":"116","author":"Tong","year":"2009","journal-title":"Ophthalmology"},{"key":"B46-20240828","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"B47-20240828","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) study:A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"B48-20240828","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study:Phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"key":"B49-20240828","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ophtha.2020.06.004","article-title":"Effects on ocular biometrics by 0.05%, 0.025%, and 0.01% atropine:Low-concentration Atropine for Myopia Progression (LAMP) study","volume":"127","author":"Li","year":"2020","journal-title":"Ophthalmology"},{"key":"B50-20240828","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in India:Multicentric randomized trial","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"key":"B51-20240828","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40123-019-0194-6","article-title":"A pilot study on the efficacy and safety of 0.01% atropine in German schoolchildren with progressive myopia","volume":"8","author":"Joachimsen","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"B52-20240828","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.oftal.2017.12.015","article-title":"Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness","volume":"93","author":"Diaz-Llopis","year":"2018","journal-title":"Arch Soc Espanola Oftalmol"},{"key":"B53-20240828","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1111\/aos.14166","article-title":"Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients","volume":"97","author":"Sacchi","year":"2019","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B54-20240828","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/jop.2015.0043","article-title":"Atropine 0.01% eyedrops significantly reduce the progression of childhood myopia","volume":"31","author":"Clark","year":"2015","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"key":"B55-20240828","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ajo.2015.01.029","article-title":"Risk factors for progressive myopia in the atropine therapy for myopia study","volume":"159","author":"Loh","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B56-20240828","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0014-4835(91)90027-C","article-title":"Muscarinic antagonist effects on experimental chick myopia","volume":"52","author":"Stone","year":"1991","journal-title":"Exp Eye Res"},{"key":"B57-20240828","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/108076803321908392","article-title":"A tolerability study of pirenzepine ophthalmic gel in myopic children","volume":"19","author":"Bartlett","year":"2003","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"key":"B58-20240828","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ophtha.2007.11.018","article-title":"Tropicamide and myopia progression","volume":"115","author":"Iribarren","year":"2008","journal-title":"Ophthalmology"},{"key":"B59-20240828","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/bjo.83.12.1370","article-title":"Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, or L-ornithine","volume":"83","author":"Trier","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"B60-20240828","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12177-008-9013-3","article-title":"Systemic 7-methylxanthine in retarding axial eye growth and myopia progression:A 36-month pilot study","volume":"1","author":"Trier","year":"2008","journal-title":"J Ocul Biol Dis Infor"},{"key":"B61-20240828","first-page":"1","article-title":"Myopia progression in young school children. A prospective study of myopia progression and the effect of a trial with bifocal lenses and beta blocker eye drops","author":"Jensen","year":"1991","journal-title":"Acta Ophthalmol Suppl"},{"key":"B62-20240828","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/S0042-6989(02)00258-4","article-title":"Undercorrection of myopia enhances rather than inhibits myopia progression","volume":"42","author":"Chung","year":"2002","journal-title":"Vision Res"},{"key":"B63-20240828","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1444-0938.2006.00055.x","article-title":"The possible effect of undercorrection on myopic progression in children","volume":"89","author":"Adler","year":"2006","journal-title":"Clin Exp Optom"},{"key":"B64-20240828","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/OPX.0b013e3181ea19c7","article-title":"Spectacle lenses designed to reduce progression of myopia:12-month results","volume":"87","author":"Sankaridurg","year":"2010","journal-title":"Optom Vis Sci"},{"key":"B65-20240828","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamaophthalmol.2013.7623","article-title":"Effect of bifocal and prismatic bifocal spectacles on myopia progression in children:Three-year results of a randomized clinical trial","volume":"132","author":"Cheng","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"B66-20240828","first-page":"1166","article-title":"Five\u2013year results from the correction of?myopia evaluation trial (COMET)","volume":"47","author":"Gwiazda","year":"2006","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"B67-20240828","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.survophthal.2011.06.002","article-title":"Multifocal versus single vision lenses intervention to slow progression of myopia in school-age children:A meta-analysis","volume":"56","author":"Li","year":"2011","journal-title":"Surv Ophthalmol"},{"key":"B68-20240828","first-page":"1535","article-title":"Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude:low-dose atropine and myopia progression","volume":"104","author":"Fu","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"B69-20240828","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1167\/iovs.12-11462","article-title":"Myopia control with positively aspherized progressive addition lenses:A 2-year, multicenter, randomized, controlled trial","volume":"55","author":"Hasebe","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B70-20240828","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression:A 2-year randomised clinical trial","volume":"104","author":"Lam","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"B73-20240828","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1475-1313.2008.00608.x","article-title":"The effectiveness of progressive addition lenses on the progression of myopia in Chinese children","volume":"29","author":"Yang","year":"2009","journal-title":"Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt Optom"},{"key":"B74-20240828","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1475-1313.2008.00608.x","article-title":"The effectiveness of progressive addition lenses on the progression of myopia in Chinese children","volume":"29","author":"Yang","year":"2009","journal-title":"Ophthalmic Physiol Opt"},{"key":"B75-20240828","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.02-0816","article-title":"A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children","volume":"44","author":"Gwiazda","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B76-20240828","first-page":"507","article-title":"Nonoptical determinants of aniseikonia","volume":"24","author":"Bradley","year":"1983","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B77-20240828","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/ICL.0000000000000222","article-title":"Changes in peripheral refraction, higher-order aberrations, and accommodative lag with a radial refractive gradient contact lens in young myopes","volume":"42","author":"Paun\u00e9","year":"2016","journal-title":"Eye Contact Lens"},{"key":"B78-20240828","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/OPX.0000000000001106","article-title":"A randomized trial of soft multifocal contact lenses for myopia control:Baseline data and methods","volume":"94","author":"Walline","year":"2017","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"B79-20240828","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/OPX.0000000000000036","article-title":"Multifocal contact lens myopia control","volume":"90","author":"Walline","year":"2013","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"B80-20240828","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2147\/OPTH.S66884","article-title":"Effect of low-addition soft contact lenses with decentered optical design on myopia progression in children:A pilot study","volume":"8","author":"Fujikado","year":"2014","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"B81-20240828","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bjophthalmol-2013-303914","article-title":"Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren:A 2-year randomised clinical trial","volume":"98","author":"Lam","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"B82-20240828","doi-asserted-by":"crossref","first-page":"507572","DOI":"10.1155\/2015\/507572","article-title":"Myopia control with a novel peripheral gradient soft lens and orthokeratology:A 2-year clinical trial","volume":"2015","author":"Paun\u00e9","year":"2015","journal-title":"Biomed Res Int"},{"key":"B83-20240828","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1167\/iovs.11-7260","article-title":"Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia:One-year results","volume":"52","author":"Sankaridurg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B84-20240828","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia control","volume":"96","author":"Chamberlain","year":"2019","journal-title":"Optometry Vis Sci"},{"key":"B85-20240828","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jama.2020.10834","article-title":"Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children:The BLINK randomized clinical trial","volume":"324","author":"Walline","year":"2020","journal-title":"JAMA"},{"key":"B87-20240828","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI \u2013Interventions for controlling myopia onset and progression report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B88-20240828","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/02713680590907256","article-title":"The longitudinal orthokeratology research in children (LORIC) in Hong Kong:A pilot study on refractive changes and myopic control","volume":"30","author":"Cho","year":"2005","journal-title":"Curr Eye Res"},{"key":"B89-20240828","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of myopia in Orthokeratology (ROMIO) study:A 2-year randomized clinical trial","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B90-20240828","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clae.2013.02.012","article-title":"High myopia-partial reduction orthokeratology (HM-PRO):Study design","volume":"36","author":"Charm","year":"2013","journal-title":"Contact Lens Anterior Eye J Br Contact Lens Assoc"},{"key":"B91-20240828","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1167\/iovs.13-12527","article-title":"Myopia control using toric orthokeratology (TO-SEE study)","volume":"54","author":"Chen","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"B92-20240828","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00417-018-3906-z","article-title":"MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial","volume":"256","author":"Ruiz-Pomeda","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B93-20240828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","article-title":"Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia:First year results","volume":"62","author":"Kinoshita","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"B94-20240828","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/02713683.2019.1568501","article-title":"Combined atropine with orthokeratology for myopia control:Study design and preliminary results","volume":"44","author":"Tan","year":"2019","journal-title":"Curr Eye Res"},{"key":"B95-20240828","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2147\/OPTH.S141404","article-title":"In vitro release of two anti-muscarinic drugs from soft contact lenses","volume":"11","author":"Hui","year":"2017","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"B96-20240828","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/OPX.0000000000001378","article-title":"Bifocal &atropine in myopia study:Baseline data and methods","volume":"96","author":"Huang","year":"2019","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2098_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:08:49Z","timestamp":1787756929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2098_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2098_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"2021-08-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}